A new CAR T-cell therapy has shown lasting benefits for people with stiff person syndrome. Patients at the University of Colorado Anschutz had better mobility and less disability for at least one year after treatment.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
CAR T-cell therapy shows lasting improvements in stiff person syndrome, study finds

CAR T-Cell Therapy Treatment type
12 Months Improvement duration
Stiff Person Syndrome Condition
90% patients improved
Lasting 12 Months disability reduced